# A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression

> **NCT03460756** · PHASE2 · COMPLETED · sponsor: **Marinus Pharmaceuticals** · enrollment: 84 (actual)

## Conditions studied

- Depressive Disorder
- Depression
- Depression, Postpartum
- Behavioral Symptoms
- Mood Disorders
- Mental Disorder
- Pregnancy Complications
- Postpartum Blues
- PPD
- Postpartum Disorder

## Interventions

- **DRUG:** Ganaxolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03460756
- **Lead sponsor:** Marinus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-28
- **Primary completion:** 2019-07-05
- **Final completion:** 2019-07-05
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03460756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03460756, "A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03460756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*